Material and methods Study design and population We applied a new-user, active comparator cohort study design, comparing GLP-1 RA users with SGLT-2 inhibitor users and GLP-1 RA users with DPP-4 inhibitor users on the incidence of suicide or suicide attempts [19], utilizing information from registers on the entire Danish population [20]
However, weight-loss drugs are included in a small group of drugs that can be excluded from coverage 1 (though the statutory exception refers to agents used for weight loss, obesity drugs is used to refer to this group of medications in this analysis)
Compared to patients who were prescribed GLP-1 RAs or who had no treatment, patients who underwent surgery tended to be more medically complex
Our providers carefully evaluate each patients full medical history before beginning treatment
A Comprehensive Approach for Better Outcomes By integrating GLP-1 therapies with gut health strategies and holistic lifestyle interventions, physicians can tackle metabolic dysfunction comprehensively
Muratori F, Di Sacco G, Pellegrino D, Vignati F
